Historical record - last NADAC publication: 6/21/2023

Product Information

METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0626 per EA under NDC 70010049205. Its NADAC has been published 203 times since Aug 28, 2019.

METFORMIN HCL ER 750 MG TABLET

Metformin ER 750 mg
$0.0626per EA

Strength

750 mg/1

NDC

70010049205

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

6/21/2023

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209313

On Market Since

7/31/2018

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 203 times since Aug 28, 2019, and over the history we have for it it has declined 8.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0626 per EA
All-time high$0.0942 (Feb 10, 2021)
All-time low$0.0553 (Jan 22, 2020)
Median price$0.0691
Average price$0.0727
Largest weekly change+26.5% (Dec 23, 2020)
Weeks tracked203
Tracking sinceAug 28, 2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-22.6%

All

-8.6%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0626 per EA (NDC 70010049205), effective Jul 12, 2023.

How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 8.6%. It has been tracked across 203 weekly CMS publications since Aug 28, 2019.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?

Since Aug 28, 2019, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0553 (Jan 22, 2020) to a high of $0.0942 (Feb 10, 2021), with a median of $0.0691 per EA.

Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL ER 750 MG TABLET, is $0.0548 per EA — about 12% below METFORMIN HCL ER 750 MG TABLET.

Who manufactures METFORMIN HCL ER 750 MG TABLET?

METFORMIN HCL ER 750 MG TABLET (NDC 70010049205) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.